Anagenics Continues Talks With ASX to Lift Trading Suspension

MT Newswires Live

2025/01/06

Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.

The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.

In the same filing, the company confirmed US-based Roquefort Therapeutics' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2501444008"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501444008\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2501444008?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-06 05:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501444008","market":"sg","top_or_hot":-1,"title":"Anagenics Continues Talks With ASX to Lift Trading Suspension","media":"MT Newswires Live","content":"<html><body><p> Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.</p><p>The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.</p><p>In the same filing, the company confirmed US-based Roquefort <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Anagenics Continues Talks With ASX to Lift Trading Suspension</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnagenics Continues Talks With ASX to Lift Trading Suspension\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-01-06 05:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.</p><p>The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.</p><p>In the same filing, the company confirmed US-based Roquefort <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XAO.AU","symbol_name":"标普/澳交所 普通股指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501444008","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501444008","pubTimestamp":1736112544,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Anagenics  said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.In the same filing, the company confirmed US-based Roquefort Therapeutics' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XAO.AU":"标普/澳交所 普通股指数","BK7508":"医药生物股","BK7111":"个人用品","XJO.AU":"标普/澳交所 200指数","XKO.AU":"标普/澳交所 300指数","AN1.AU":"Anagenics Ltd"},"translate_title":"Anagenics继续与ASX谈判以解除交易暂停","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XJO.AU":0.89,"XAO.AU":0.89,"AN1.AU":0.9,"XKO.AU":0.89},"content_text":"Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.In the same filing, the company confirmed US-based Roquefort Therapeutics' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}